Close Menu

intellectual property

The company exited the NGS whole-genome analysis market a few years ago and is now focused on building a business around its core IP search technology.

Hologic said in its Form 10-Q that Enzo sued the firm in March alleging infringement of a patent related to labeled nucleotides for use as diagnostic tools.

The appeals court reversed in part an earlier decision by aUSdistrict court that resulted in a $61 million award to Enzo, and remanded the case back to the district court.

Illumina and its subisidiary Verinata allege Premaitha's Iona test infringes two European patents relating to the use of cell-free fetal DNA for NIPT.

10X Genomics' GemCode platform

Several early-access customers presented results from the 10X technology at the meeting.

The IP covers the detection of histone modifications in cell-free nucleosomes from circulating cancer cells.

In a statement to GenomeWeb, Myriad noted that all seven of its cases are now settled, "which ends the BRCA litigation."

The parties have decided to drop their claims and counterclaims against eachother ending a patent infringement lawsuit on BRCA testing.

NabSys has been awarded

NEW YORK (GenomeWeb) – A recently launched lawsuit in Canada challenging the practice of patenting genomic DNA is also asking the Federal Court to determine that advanced diagnostics utilizing next-generation sequencing platforms do not infringe patents on older testing methods involving the ampl

Pages

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.